Press release
The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis
Companion Diagnostics market
The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of R&D and production facilities that can be accessed through service providers.
To order this 660+ page report, which features 190+ figures and 260+ tables, please visit https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
Key Market Insights
Over 150 companies claim to offer companion diagnostics development services, globally
Nearly 60% of the aforementioned players are based in North America, followed by the players located in Europe (30%). Further, this segment of the industry is dominated by the presence of mid-sized players (51-200 employees), which represent 40% of the total service providers.
Nearly 15% players claim to act as one-stop shops, offering services, ranging from biomarker discovery and development to manufacturing and commercialization
Most of the service providers (127) provide assay development services, followed by companies (124) offering services for biomarker discovery / identification. Further, NGS is the most popular technique, employed by over 100 service providers.
Over 90 companies are actively involved in companion diagnostics development
Nearly 91% of the total tests can detect mutations in a single biomarker. Amongst these, ErbB gene family (HER-2 and EGFR genes), PD-L1 genes, RAS gene family (KRAS and NRAS genes), BRCA gene family (BRCA1 and BRCA2) and BRAF emerged as the key genes which are assessed by majority of the companion diagnostics.
Partnership activity in this domain has increased at a CAGR of ~25%, between 2017 and 2021
Mergers and acquisitions, product development agreements and product development and commercialization agreements account for more than 60% of the total number of deals inked during the given time period. It is worth highlighting that nearly 25% of the total number of deals were signed in 2021. Further, the maximum number (177) of partnerships have been inked for companion diagnostics being developed for the treatment of oncological disorders.
North America is expected to capture ~60% share in the companion diagnostics services market by 2035
Owing to the high costs associated with the clinical validation of companion diagnostics, a significant proportion (~46%) of service revenues is generated from this step, in 2035. In terms of analytical technique used, service contracts involving NGS are anticipated to contribute to more than 35% of the total service revenues generated in 2035. Further, close to 90% of the total service revenues, in 2035, are generated from companion diagnostics development projects for cancer indications.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/companion-diagnostics-services/request-sample.html
Key Questions Answered
* Who are the leading players offering services for the development of companion diagnostics?
* Which are the key geographies where companion diagnostics development service providers are located?
* Which analytical techniques are used by the service providers engaged in companion diagnostics services market?
* Who are the leading companion diagnostics developers?
* Which biomarkers are most commonly targeted by the marketed products / investigational programs?
* Which partnership models are commonly adopted by stakeholders offering companion diagnostics services?
* Which drug developers are most likely to partner with the service providers to seek their expertise?
* What are the key value drivers of the merger and acquisition activity within companion diagnostics development services market?
* Which biomarker-focused targeted drugs developed by big pharmaceutical companies are likely to be administered with companion diagnostics?
* How is the current and future opportunity likely to be distributed across companion diagnostics market?
The financial opportunity within the companion diagnostics services market has been analyzed across the following segments:
* Type of Service Offered
- Feasibility Studies
- Assay Development
- Analytical Validation
- Clinical Validation
- Manufacturing
* Type of Technique Used
- NGS
- PCR
- ICH / ISH
- Liquid Biopsy
- Others
* Therapeutic Areas
- Oncological
- Non-oncological
* Key Geographical Regions
- North America
- Europe
- Asia-Pacific and Rest of the World
The report also features detailed transcripts of discussions (in reverse chronological order) held with the following experts:
* Mike Klein (Chief Executive Officer, Genomenon)
* Mark Kiel (Founder and Chief Scientific Officer, Genomenon)
* Candace Chapman (Vice President of Marketing, Genomenon)
* Anton Iliuk (President and Chief Technology Officer, Tymora Analytical Operations)
* Paul Kortschak (Former Senior Vice President, Novodiax)
* Pablo Ortiz (Chief Executive officer, OWL Metabolomics)
* Lawrence Weiss (Former Chief Scientific Officer, NeoGenomics Laboratories)
The research includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), drug portfolio, details on recent developments, and an informed future outlook.
* Almac Diagnostic Services
* BGI Genomics
* Biocartis
* Cerba Research
* Geneuity Clinical Research Services
* Interpace Biosciences
* Labcorp (formerly known as Covance)
* MEDICAL & BIOLOGICAL LABORATORIES (MBL)
* MEDx (Suzhou) Translational Medicine (formerly known as QIAGEN (Suzhou) Translational Medicine)
* MLM Medical Labs
* Novogene
* Q2 Solutions
* Quest Diagnostics
* ResearchDx
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
- Flow Cytometry Services Market, 2022-2035
- Precision Medicine Software Developers Market, 2021-2031
- Next Generation Sequencing (NGS) Kits Market, 2022-2035
- Cell and Gene Therapy Bioassay Services Market, 2021-2031
- Point-of-Care Diagnostics Market, 2020-2025
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis here
News-ID: 2689980 • Views: …
More Releases from Roots Analysis
Biomarkers Market Growth Driven by Precision Medicine and Advanced Diagnostics | …
Roots Analysis has published its latest Biomarkers Market report, offering a comprehensive analysis of one of the fastest-growing segments of the life sciences and healthcare industry. The study provides detailed insights into market trends, technological advancements, competitive dynamics, emerging opportunities, and future growth prospects across the global biomarkers ecosystem.
The report presents an in-depth evaluation of market drivers, challenges, regulatory landscape, investment activity, partnership trends, technological innovations, and commercialization opportunities expected…
Autoinjectors Market to Reach USD 299 Billion by 2035 at 5.7% CAGR | SHL Medical …
The global autoinjectors market, valued at USD 170 billion in 2025, will reach USD 181 billion in 2026 and climb to USD 299 billion by 2035, advancing at a CAGR of 5.7% over the forecast period. The growth reflects accelerating demand for self-administration devices across chronic disease management, a wave of biosimilar launches entering autoinjector formats, and a measurable shift in patient care from clinical settings to home environments.
To access…
Antiviral Drugs Market to Reach USD 127 Billion by 2035, Growing at 6.1% CAGR | …
The global antiviral drugs market, valued at USD 69 billion in 2025, will reach USD 74 billion in 2026 and climb to USD 127 billion by 2035, advancing at a CAGR of 6.1% over the forecast period. Infectious disease burden, accelerating R&D pipelines, and the post-pandemic push for novel antivirals are collectively reshaping this market into one of the pharmaceutical sector's most active growth categories.
To explore the complete findings, request…
Antibody Drug Conjugate (ADC) Market to Reach $28.41 Billion by 2035 | AstraZene …
The global antibody drug conjugate (ADC) market, valued at USD 15.29 billion in 2025, will grow to USD 18.69 billion in 2026 and reach USD 28.41 billion by 2035, advancing at a CAGR of 4.8% through the forecast period. With 19 approved therapies already on the market and an active clinical pipeline spanning hundreds of programs, the ADC sector has moved well past proof-of-concept and into a sustained commercial expansion…
More Releases for Mark
MARK WAHLBERG INSTANT EARWORMS!
A jingle for Mark Wahlberg and Wahlburgers ( link below ). Host and enthusiastic Wahlburgers fan DeeDee from CRAZY JOURNEYS with DeeDee is putting out an open invitation to Mark Wahlberg himself - to join her for a fun, fresh photo retake at one of his legendary Wahlburgers locations.
Why? Because every great journey deserves a great snapshot- and the magic of an awesome burger.
DeeDee, whose content on YouTube has…
INTERVIEW: MARK JAMES SCOTT
I sat down with Brand Consultant, Designer & Creative Director Mark James Scott who is making an Impact in the Hip Hop World, in both the UK and the US. We talked working with Artists from The Game and Music Mogul Diddy, to his own Music and more..
BY SASHA JENKINS
WHAT SETS YOU APART FROM OTHERS IN YOUR FIELD?
I didn't study Design. I studied Psychology for 6 years and gained my Masters…
Impressionist landscape artist - Mark Briscoe
I am Mark Briscoe, Bristish artist well established in the field of Chinoiserie furniture decoration and restoration of antique lacquer. But the techniques for fine art easel painting in the wonderful manner of the old masters is something which I have been exploring in great earnest over the last two years as a long cherished desire. And while I cannot claim to have come anywhere near their heights, I have…
Mark de Clive-Lowe
On Thursday, May 3rd, 2012 internationally known musician Mark de Clive-Lowe (MdCL), will take the stage at The Beehive, located in Boston, MA, for a special performance of his revolutionary sound. Be there from 9:30PM to 1:00AM as MdCL plays impromptu remixes created from scratch, on the spot using drum machines, keyboards and special effects. He will start with a jazz-oriented set and crank up the intensity with his signature…
Trade Mark Act
Neoinfo Solutions Pvt. LTD is an IT based company with its main office located in Jaipur(rajasthan). Our expertise lies in the domain of Website Designing development portal development,maintenance software consulting, designing development , implimentation, training and maitenance.In the journey of achieving our combined business and social goals we have kept in mind and have always strictly followed all our data security policies to ensure that all informations of our clients…
Trade mark Act
Neoinfo Solutions Pvt. LTD is an IT based company with its main office located in Jaipur(rajasthan). Our expertise lies in the domain of Website Designing development portal development,maintenance software consulting, designing development , implimentation, training and maitenance.In the journey of achieving our combined business and social goals we have kept in mind and have always strictly followed all our data security policies to ensure that all informations of our clients…
